Innovative Diagnostics for Public Health

InBios International Inc. specializes in the design, development and manufacture of diagnostic devices for emerging infectious diseases and biothreats. Founded in 1996 in Seattle, WA, our superior quality products are accurate, easy to use and cost effective.

InBios offers an extensive catalog of life science reagents, along with a portfolio of more than 25 diagnostic products, including FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified.

Read More

High Quality Diagnostic Solutions for COVID-19

InBios’ COVID-19 products meet our high standards of quality, safety and accuracy. Three products – Smart Detect™ SARS-CoV-2 rRT PCR Kit, SCoV-2 Detect™ IgM ELISA Kit and SCoV-2 Detect™ IgG ELISA Kit – have received FDA Emergency Use Authorization (EUA) and are now CE Marked.

Check our COVID-19 page or join our mailing list for frequent updates.

Sign Up for InBios Email

Conference Exhibitions

InBios in the News


Zika   •   Chikungunya   •   Dengue   •   West Nile   •   Japanese Encephalitis   •   Scrub Typhus   •   Visceral Leishmaniasis   •   Cutaneous Leishmaniasis   •   Chagas   •   Filariasis   •   Strongyloides   •   Leptospirosis   •   Melioidosis   •   Norovirus

Current Newsletter
View Past Newsletters
Sign Up for InBios Email